Lactic acid bacterium reuteri prodentis improves treatment of periodontitis

A double-blind, placebo-controlled study of patients with chronic periodontitis showed that the use of lactic acid bacterium reuteri Prodentis as an adjunct to standard treatment significantly increased the effectiveness of such treatment by 53 percent.  

The aim of the study was to evaluate the effect of the lactic acid bacterium reuteri Prodentis in addition to the removal of tartar and smoothing the surface of the roots of the tooth, which is a standard treatment for patients with chronic periodontitis.  

After completion of the 12-week study, patients with deep periodontal pockets treated with lactic acid bacterium reuteri Prodentis had 53 percent fewer sites (tooth surfaces) requiring treatment compared with the placebo group (p ˂ 0.019)  operations. A place that required a surgical operation – this is a periodontal pocket, the depth of which was ≥ 6 mm or > 5 mm with bleeding.  

After the procedure, it was also concluded that 67 percent of patients in the placebo group fell into the category of high risk of disease progression, while the corresponding figure for patients treated with lactic acid bacteria reuteri Prodentis was only 27 percent (p ˂ 0.027). In the published article, the authors emphasize that these figures can be compared with the results that were published as a result of conducting different studies using a combination of two different antibiotics in addition to removing tartar and leveling the surface of the roots of the tooth.

Among patients with more severe problems in the group treated with lactobacillus reuteri Prodentis, compared with patients in the placebo group, there was a much greater reduction in periodontal pockets and attachment efficiency (p ˂ 0.05).  

The study, which was published online on August 15, 2013 in the journal Clinical Periodontology, included 30 patients.  

"This study is important because it shows that fewer patients will need surgery. And that's great cost and nerve savings with BioGaia ProDentis. The results of the study will also help many practicing dentists and dental clinics around the world", &ndash ; says Peter Rothchild, president of BioGaia. 

Source: estet-portal.com.